Frank Meyskens
Frank Meyskens
Professor of Medicine
Verified email at uci.edu - Homepage
TitleCited byYear
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
GS Omenn, GE Goodman, MD Thornquist, J Balmes, MR Cullen, A Glass, ...
New England journal of medicine 334 (18), 1150-1155, 1996
39771996
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
SM Lippman, EA Klein, PJ Goodman, MS Lucia, IM Thompson, LG Ford, ...
Jama 301 (1), 39-51, 2009
21182009
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
EA Klein, IM Thompson, CM Tangen, JJ Crowley, MS Lucia, PJ Goodman, ...
Jama 306 (14), 1549-1556, 2011
13452011
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
GS Omenn, GE Goodman, MD Thornquist, J Balmes, MR Cullen, A Glass, ...
JNCI: Journal of the National Cancer Institute 88 (21), 1550-1559, 1996
13251996
Polyamines and cancer: old molecules, new understanding
EW Gerner, FL Meyskens Jr
Nature Reviews Cancer 4 (10), 781, 2004
9762004
Reactive oxygen species: a breath of life or death?
JP Fruehauf, FL Meyskens
Clinical Cancer Research 13 (3), 789-794, 2007
8782007
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
J Cuzick, F Otto, JA Baron, PH Brown, J Burn, P Greenwald, J Jankowski, ...
The lancet oncology 10 (5), 501-507, 2009
6622009
Retinoids as preventive and therapeutic anticancer agents (Part I).
SM Lippman, JF Kessler, JFL Meyskens
Cancer treatment reports 71 (4), 391-405, 1987
5661987
Rationale and strategies for chemoprevention of cancer in humans
JS Bertram, LN Kolonel, FL Meyskens
Cancer research 47 (11), 3012-3031, 1987
5151987
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial
FL Meyskens, CE McLaren, D Pelot, S Fujikawa-Brooks, PM Carpenter, ...
Cancer prevention research 1 (1), 32-38, 2008
4372008
Quality of life end points in cancer clinical trials: review and recommendations
CMM Moinpour, P Feigl, B Metch, KA Hayden, FL Meyskens Jr, J Crowley
JNCI: Journal of the National Cancer Institute 81 (7), 485-496, 1989
4361989
The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol …
GE Goodman, MD Thornquist, J Balmes, MR Cullen, FL Meyskens Jr, ...
Journal of the National Cancer Institute 96 (23), 1743-1750, 2004
4152004
Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study
DJ Ahnen, P Feigl, G Quan, C Fenoglio-Preiser, LC Lovato, PA Bunn, ...
Cancer research 58 (6), 1149-1158, 1998
4041998
Development of difluoromethylornithine (DFMO) as a chemoprevention agent
FL Meyskens, EW Gerner
Clinical Cancer Research 5 (5), 945-951, 1999
4021999
Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development: recommendations of the American association for cancer …
JA O’Shaughnessy, GJ Kelloff, GB Gordon, AJ Dannenberg, WK Hong, ...
Clinical Cancer Research 8 (2), 314-346, 2002
4012002
Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia
RE Carroll, RV Benya, DK Turgeon, S Vareed, M Neuman, L Rodriguez, ...
Cancer prevention research 4 (3), 354-364, 2011
3752011
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy
HCF Moore, JM Unger, KA Phillips, F Boyle, E Hitre, D Porter, PA Francis, ...
New England Journal of Medicine 372 (10), 923-932, 2015
3562015
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial
TM Brasky, AK Darke, X Song, CM Tangen, PJ Goodman, IM Thompson, ...
Journal of the National Cancer Institute 105 (15), 1132-1141, 2013
3102013
The β-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers
GS Omenn, G Goodman, M Thornquist, J Grizzle, L Rosenstock, ...
Cancer research 54 (7 Supplement), 2038s-2043s, 1994
2901994
Enhancement of Regression of Cervical Intraepithelial Neoplasia II (Moderate Dysplasia) With Topically Applied All- trans -Retinoic Acid: a Randomized Trial
FL Meyskens, E Surwit, TE Moon, JM Childers, JR Davis, RT Dorr, ...
JNCI: Journal of the National Cancer Institute 86 (7), 539-543, 1994
2891994
The system can't perform the operation now. Try again later.
Articles 1–20